Abstract | BACKGROUND: OBJECTIVES: METHODS: A 6-month, randomized, multinational (16 countries), multicenter (80 sites) clinical trial with an open-label, crossover design was performed in 722 patients with NIDDM. Insulin lispro was injected immediately before and human regular insulin 30 to 45 minutes before the meal. RESULTS: CONCLUSIONS:
|
Authors | J H Anderson Jr, R L Brunelle, P Keohane, V A Koivisto, M E Trautmann, L Vignati, R DiMarchi |
Journal | Archives of internal medicine
(Arch Intern Med)
Vol. 157
Issue 11
Pg. 1249-55
(Jun 09 1997)
ISSN: 0003-9926 [Print] United States |
PMID | 9183237
(Publication Type: Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial)
|
Chemical References |
- Blood Glucose
- Glycated Hemoglobin A
- Hypoglycemic Agents
- Insulin
- Insulin Lispro
- Lipids
- Lipoproteins
|
Topics |
- Blood Glucose
(metabolism)
- Cross-Over Studies
- Diabetes Mellitus, Type 2
(blood, drug therapy)
- Female
- Food
- Glycated Hemoglobin
(analysis)
- Humans
- Hyperglycemia
(prevention & control)
- Hypoglycemia
(prevention & control)
- Hypoglycemic Agents
(administration & dosage, pharmacokinetics, therapeutic use)
- Insulin
(administration & dosage, analogs & derivatives, pharmacokinetics, therapeutic use)
- Insulin Lispro
- Lipids
(blood)
- Lipoproteins
(blood)
- Male
- Middle Aged
|